Corbus Pharmaceuticals Holdings, Inc.
US ˙ NasdaqCM ˙ US21833P3010

SecurityCRBP / Corbus Pharmaceuticals Holdings, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership52,836 shares
Latest Disclosed Value $ 496,130
Simplex Trading, Llc ownership in CRBP / Corbus Pharmaceuticals Holdings, Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 52,836 shares of Corbus Pharmaceuticals Holdings, Inc. (US:CRBP) valued at $496,130 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 0 shares of Corbus Pharmaceuticals Holdings, Inc.. The current value of the position is $389,930 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (CRBP) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CRBP / Corbus Pharmaceuticals Holdings, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM 21833P301 52,836 52,836 496 0.0002
2026-02-11 2025-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM 21833P301 0 -17,950 -100.00 0 0.0000
2025-11-12 2025-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM 21833P301 17,950 15,131 536.75 0 0.0001
2025-08-05 2025-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM 21833P301 2,819 -3,054 -52.00 0 0.0000
2025-05-12 2025-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM 21833P301 5,873 4,974 553.28 0 0.0000
2025-02-11 2024-12-31 13F CORBUS PHARMACEUTICALS HLDGS COM 21833P301 899 899 0 0.0000
2024-11-08 2024-09-30 13F CORBUS PHARMACEUTICALS HLDGS COM 21833P301 0 -1,727 -100.00 0 0.0000
2024-07-25 2024-06-30 13F CORBUS PHARMACEUTICALS HLDGS COM 21833P301 1,727 -263 -13.22 0 0.0000
2024-04-25 2024-03-31 13F CORBUS PHARMACEUTICALS HLDGS COM 21833P301 1,990 1,990 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-04-27 2023-03-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 0 -100.00 0 n/a n/a n/a
2023-02-02 2022-12-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 116,100 -2.03 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 118,500 -7.20 19 -40.62 n/a n/a n/a
2022-08-03 2022-06-30 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 127,700 -4.49 32 -54.93 n/a n/a n/a
2022-05-02 2022-03-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 133,700 60.89 71 39.22 n/a n/a n/a
2022-02-23 2021-12-31 13F/A CORBUS PHARMACEUTICALS HLDGS CALL Call 83,100 39.20 51 -52.78 n/a n/a n/a
2022-02-04 2021-12-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 59,700 108 n/a n/a n/a
2021-10-28 2021-09-30 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 59,700 0.51 108 0.00 n/a n/a n/a
2021-08-12 2021-06-30 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 59,400 5,016.28 108 -52.63 n/a n/a n/a
2021-04-26 2021-03-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 1,161 41.41 228 123.53 n/a n/a n/a
2021-02-02 2020-12-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 821 -67.92 102 -77.83 n/a n/a n/a
2020-10-14 2020-09-30 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 2,559 318.14 460 -10.33 n/a n/a n/a
2020-07-13 2020-06-30 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 612 -39.88 513 -3.75 n/a n/a n/a
2020-04-29 2020-03-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 1,018 128.25 533 119.34 n/a n/a n/a
2020-02-05 2019-12-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 446 682.46 243 800.00 n/a n/a n/a
2019-10-15 2019-09-30 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 57 -33.72 27 -54.24 n/a n/a n/a
2019-07-26 2019-06-30 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 86 -25.22 59 -25.32 n/a n/a n/a
2019-04-18 2019-03-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 115 130.00 79 172.41 n/a n/a n/a
2019-01-16 2018-12-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 50 4,900.00 29 -63.29 n/a n/a n/a
2018-10-23 2018-09-30 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 1 -95.83 0 -100.00 n/a n/a n/a
2018-07-30 2018-06-30 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 24 -75.76 12 1,100.00 n/a n/a n/a
2018-04-26 2018-03-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 99 312.50 1 -91.67 n/a n/a n/a
2018-01-10 2017-12-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-10-25 2017-09-30 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 165 -37.97 10 900.00 n/a n/a n/a
2017-07-12 2017-06-30 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 266 -52.07 1 -94.74 n/a n/a n/a
2017-04-21 2017-03-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 555 96.11 19 -40.62 n/a n/a n/a
2017-01-11 2016-12-31 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 283 28,200.00 32 68.42 n/a n/a n/a
2016-10-07 2016-09-30 13F CORBUS PHARMACEUTICALS HLDGS CALL Call 1 0 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-04-27 2023-03-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 0 -100.00 0 n/a n/a n/a
2023-02-02 2022-12-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 16,300 2.52 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 15,900 -46.28 2 -71.43 n/a n/a n/a
2022-08-03 2022-06-30 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 29,600 -1.33 7 -53.33 n/a n/a n/a
2022-05-02 2022-03-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 30,000 -50.74 15 -59.46 n/a n/a n/a
2022-02-23 2021-12-31 13F/A CORBUS PHARMACEUTICALS HLDGS PUT Put 60,900 -74.65 37 -91.53 n/a n/a n/a
2022-02-04 2021-12-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 240,200 437 n/a n/a n/a
2021-10-28 2021-09-30 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 240,200 0.00 437 -0.46 n/a n/a n/a
2021-08-12 2021-06-30 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 240,200 61,332.23 439 470.13 n/a n/a n/a
2021-04-26 2021-03-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 391 40.65 77 126.47 n/a n/a n/a
2021-02-02 2020-12-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 278 -89.88 34 -93.12 n/a n/a n/a
2020-10-14 2020-09-30 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 2,748 31.17 494 -71.88 n/a n/a n/a
2020-07-13 2020-06-30 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 2,095 1,287.42 1,757 2,124.05 n/a n/a n/a
2020-04-29 2020-03-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 151 -38.37 79 -40.60 n/a n/a n/a
2020-02-05 2019-12-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 245 380.39 133 454.17 n/a n/a n/a
2019-10-15 2019-09-30 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 51 -79.18 24 -81.95 n/a n/a n/a
2019-07-26 2019-06-30 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-04-18 2019-03-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 80 -55.31 55 -47.12 n/a n/a n/a
2019-01-16 2018-12-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 179 289.13 104 205.88 n/a n/a n/a
2018-10-23 2018-09-30 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 46 2,200.00 34 3,300.00 n/a n/a n/a
2018-07-30 2018-06-30 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 2 -84.62 1 0.00 n/a n/a n/a
2018-04-26 2018-03-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 13 -71.11 1 -50.00 n/a n/a n/a
2018-01-10 2017-12-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 45 -60.87 2 -50.00 n/a n/a n/a
2017-10-25 2017-09-30 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 115 -17.27 4 -60.00 n/a n/a n/a
2017-07-12 2017-06-30 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 139 -27.60 10 -23.08 n/a n/a n/a
2017-04-21 2017-03-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 192 -61.83 13 -72.34 n/a n/a n/a
2017-01-11 2016-12-31 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 503 9,960.00 47 261.54 n/a n/a n/a
2016-10-07 2016-09-30 13F CORBUS PHARMACEUTICALS HLDGS PUT Put 5 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.